1-235759371-T-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000081.4(LYST):​c.6482A>C​(p.Glu2161Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00511 in 1,614,230 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0042 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 42 hom. )

Consequence

LYST
NM_000081.4 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:10

Conservation

PhyloP100: 5.56

Publications

14 publications found
Variant links:
Genes affected
LYST (HGNC:1968): (lysosomal trafficking regulator) This gene encodes a protein that regulates intracellular protein trafficking in endosomes, and may be involved in pigmentation. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants, though the full-length nature of some of these variants has not been determined. [provided by RefSeq, Apr 2013]
LYST Gene-Disease associations (from GenCC):
  • Chediak-Higashi syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • attenuated Chédiak-Higashi syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030755103).
BP6
Variant 1-235759371-T-G is Benign according to our data. Variant chr1-235759371-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 254931.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00421 (641/152380) while in subpopulation AMR AF = 0.00588 (90/15306). AF 95% confidence interval is 0.0049. There are 5 homozygotes in GnomAd4. There are 286 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000081.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LYST
NM_000081.4
MANE Select
c.6482A>Cp.Glu2161Ala
missense
Exon 23 of 53NP_000072.2
LYST
NM_001301365.1
c.6482A>Cp.Glu2161Ala
missense
Exon 23 of 53NP_001288294.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LYST
ENST00000389793.7
TSL:5 MANE Select
c.6482A>Cp.Glu2161Ala
missense
Exon 23 of 53ENSP00000374443.2
LYST
ENST00000489585.5
TSL:1
n.*316A>C
non_coding_transcript_exon
Exon 23 of 23ENSP00000513166.1
LYST
ENST00000489585.5
TSL:1
n.*316A>C
3_prime_UTR
Exon 23 of 23ENSP00000513166.1

Frequencies

GnomAD3 genomes
AF:
0.00422
AC:
642
AN:
152262
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00589
Gnomad ASJ
AF:
0.0354
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00525
Gnomad OTH
AF:
0.00573
GnomAD2 exomes
AF:
0.00476
AC:
1197
AN:
251264
AF XY:
0.00496
show subpopulations
Gnomad AFR exome
AF:
0.00111
Gnomad AMR exome
AF:
0.00370
Gnomad ASJ exome
AF:
0.0328
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.00517
Gnomad OTH exome
AF:
0.00767
GnomAD4 exome
AF:
0.00520
AC:
7603
AN:
1461850
Hom.:
42
Cov.:
33
AF XY:
0.00527
AC XY:
3834
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33476
American (AMR)
AF:
0.00400
AC:
179
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
924
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00289
AC:
249
AN:
86258
European-Finnish (FIN)
AF:
0.000225
AC:
12
AN:
53420
Middle Eastern (MID)
AF:
0.0109
AC:
63
AN:
5768
European-Non Finnish (NFE)
AF:
0.00516
AC:
5733
AN:
1111984
Other (OTH)
AF:
0.00692
AC:
418
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
486
972
1459
1945
2431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00421
AC:
641
AN:
152380
Hom.:
5
Cov.:
32
AF XY:
0.00384
AC XY:
286
AN XY:
74518
show subpopulations
African (AFR)
AF:
0.000986
AC:
41
AN:
41590
American (AMR)
AF:
0.00588
AC:
90
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0354
AC:
123
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.00525
AC:
357
AN:
68036
Other (OTH)
AF:
0.00567
AC:
12
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00570
Hom.:
11
Bravo
AF:
0.00468
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00616
AC:
53
ExAC
AF:
0.00428
AC:
519
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00600
EpiControl
AF:
0.00640

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Chédiak-Higashi syndrome Uncertain:1Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 23, 2022
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF: 3.3% [338/10366]; including in 7 homozygotes; https://gnomad.broadinstitute.org/variant/1-235922671-T-G?dataset=gnomad_r2_1), and in ClinVar, with several laboratories classifying it as benign or likely benign (Variation ID: 254931). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign.

Apr 13, 2016
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:4
Sep 13, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:2
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Sep 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LYST: BP4, BS2

Autoinflammatory syndrome Benign:1
Sep 17, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.15
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.18
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.70
T
MetaRNN
Benign
0.0031
T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
5.6
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.18
Sift
Uncertain
0.028
D
Sift4G
Uncertain
0.014
D
Polyphen
0.23
B
Vest4
0.21
MVP
0.60
ClinPred
0.036
T
GERP RS
2.8
Varity_R
0.099
gMVP
0.38
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147756847; hg19: chr1-235922671; COSMIC: COSV67709603; API